73: Maternal CMV screening in a large unselected population

Maternal Glycemia and Risk of Large-for-Gestational-Age Babies in a Population-Based Screening

OBJECTIVE Gestational diabetes is a risk factor for large-for-gestational-age (LGA) newborns, but many LGA babies are born to mothers with normal glucose tolerance. We aimed to clarify the association of maternal glycemia across the whole distribution with birth weight and risk of LGA births in mothers with normal glucose tolerance. RESEARCH DESIGN AND METHODS We undertook a population-based ...

Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees.

Germany continues to be iodine deficient despite considerable improvement in the past years. To assess the current prevalence of diffuse and/or nodular thyroid disorders, a cross-sectional observational study in a nonrandom sample of the working population was carried out throughout Germany in 2001 and 2002. A total of 96,278 employees 18-65 years of age from 214 companies or other private or p...

Maternal glycemia and macrosomia Maternal glycemia and risk of large for gestational age babies in a population- based screening Running title: Maternal glycemia and macrosomia

1 – National Centre for Diabetes Care, Budapest, Hungary 2 – Csepel Health Service, Department of Diabetology, Budapest, Hungary 3 – Semmelweis University Faculty of Medicine, 1st Department of Medicine, Budapest, Hungary 4 – University College London, Department of Epidemiology and Public Health, London, United Kingdom 5 – Finnish Institute of Occupational Health, Helsinki, Finland 6 – Semmelw...

Programmatic Congenital CMV Universal Screening Program

treated × 6 months) were included. Whole blood VL was determined by real-time PCR at a central laboratory before therapy (baseline, BL) and periodically for 6 months. Results. In subjects treated for 6 months, increases in BL VL correlated with decreased probability of better hearing outcomes at 12 months (Figure 1), but clinically meaningful VL thresholds that predict SNHL were not identified ...

“Targeted” Screening for Cytomegalovirus (CMV)-Related Hearing Loss: It’s Time for Universal CMV Screening in the NICU!